Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma
暂无分享,去创建一个
Sung Hun Kim | Bong Joo Kang | Hyeon Woo Yim | Byung Joo Song | B. Kang | Sung Hun Kim | B. Song | H. Yim | S. Jeong | Bo Bae Choi | Ji Hye Lee | Seung Hee Jeong | B. Choi
[1] Y. Kajiya,et al. FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[2] S. Mousa,et al. Estrogen Receptor-α in the Inhibition of Cancer Growth and Angiogenesis , 2000 .
[3] G. Hortobagyi,et al. Prognostic molecular markers in early breast cancer , 2004, Breast Cancer Research.
[4] Steven Sourbron,et al. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results. , 2008, Radiology.
[5] H. Yagata,et al. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2‐deoxy‐2‐fluoro[18F]‐D‐glucose , 1998, Cancer.
[6] Sung Hun Kim,et al. Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma , 2011, Journal of magnetic resonance imaging : JMRI.
[7] Paul J. van Diest,et al. Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography , 2002 .
[8] Masao Tanaka,et al. Standardized Uptake Values for Breast Carcinomas Assessed by Fluorodeoxyglucose-Positron Emission Tomography Correlate with Prognostic Factors , 2007, The American surgeon.
[9] Hiroshi Honda,et al. Apparent diffusion coefficients of breast tumors: clinical application. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[10] David J Collins,et al. Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy , 2008, Nature Clinical Practice Oncology.
[11] H. Tsuda,et al. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. , 2008, Japanese journal of clinical oncology.
[12] Yutaka Imai,et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer , 2008, Radiation Medicine.
[13] Takashi Kato,et al. Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity , 1996, European Journal of Nuclear Medicine.
[14] T. Yen,et al. Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[15] B. Kang,et al. Diffusion‐weighted imaging of breast cancer: Correlation of the apparent diffusion coefficient value with prognostic factors , 2009, Journal of magnetic resonance imaging : JMRI.
[16] Bong Joo Kang,et al. The Role of Diffusion-Weighted Imaging and the Apparent Diffusion Coefficient (ADC) Values for Breast Tumors , 2007, Korean journal of radiology.
[17] Masahiko Watanabe,et al. Diffusion-Weighted Imaging of Malignant Breast Tumors: The Usefulness of Apparent Diffusion Coefficient (ADC) Value and ADC Map for the Detection of Malignant Breast Tumors and Evaluation of Cancer Extension , 2005, Journal of computer assisted tomography.
[18] M. Tonato,et al. Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients , 2003, Breast Cancer Research and Treatment.
[19] Yoshito Tsushima,et al. Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5‐T , 2009, Journal of magnetic resonance imaging : JMRI.
[20] P. V. van Diest,et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] A. Razek,et al. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors , 2010, NMR in biomedicine.
[22] S G Hilsenbeck,et al. Significance of axillary lymph node metastasis in primary breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] R. Prescott,et al. Tumour cellularity, oestrogen receptors and prognosis in breast cancer. , 1983, Clinical oncology.
[24] A Horsman,et al. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. , 1997, Radiology.
[25] Shigeru Nawano,et al. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[26] A. Cilotti,et al. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion , 2007, European Radiology.
[27] Ning-Yu An,et al. Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[28] Woo Kyung Moon,et al. Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer , 2011, European Radiology.